Bristol-Myers Squibb CompanyBristol-Myers Squibb CompanyBristol-Myers Squibb Company

Bristol-Myers Squibb Company

Sem negociações
Sem negociações

Títulos de dívida corporativa

Abaixo está a lista de títulos Bristol-Myers Squibb Company, classificados pelo menor rendimento. Investidores costumam optar pelos títulos de uma empresa pela maior estabilidade em momentos de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTW %
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Classificação S&P
Classificação da Fitch
Emissor
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043
6,51%87,10%5,250%2043-08-154,06 M USD1.000,00 USD
A
Celgene Corp.
BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097
6,39%107,43%6,875%2097-08-0156,24 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047
6,37%76,51%4,350%2047-11-1513,57 M USD1.000,00 USD
A
Celgene Corp.
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048
6,32%79,21%4,550%2048-02-2037,2 M USD1.000,00 USD
A
Celgene Corp.
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044
6,13%83,74%4,625%2044-05-153,69 M USD1.000,00 USD
A
Celgene Corp.
US110122EC8Bristol-Myers Squibb Company 6.4% 15-NOV-2063
5,98%106,09%6,400%2063-11-15370,78 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EB0Bristol-Myers Squibb Company 6.25% 15-NOV-2053
5,97%103,70%6,250%2053-11-15438,54 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DX3Bristol-Myers Squibb Company 3.9% 15-MAR-2062
5,91%69,96%3,900%2062-03-151 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EL8Bristol-Myers Squibb Company 5.65% 22-FEB-2064
5,90%95,39%5,650%2064-02-22440,23 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DS4Bristol-Myers Squibb Company 2.55% 13-NOV-2050
5,89%57,10%2,550%2050-11-131,5 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EK0Bristol-Myers Squibb Company 5.55% 22-FEB-2054
5,89%95,01%5,550%2054-02-222,75 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049
5,88%79,31%4,250%2049-10-263,75 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048
5,88%83,72%4,550%2048-02-201,24 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047
5,87%81,51%4,350%2047-11-151,24 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DW5Bristol-Myers Squibb Company 3.7% 15-MAR-2052
5,87%71,23%3,700%2052-03-152 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BRMGBristol-Myers Squibb Company 4.5% 01-MAR-2044
5,83%85,39%4,500%2044-03-01341,52 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045
5,82%90,57%5,000%2045-08-15741,72 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044
5,74%87,59%4,625%2044-05-15744,72 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EJ3Bristol-Myers Squibb Company 5.5% 22-FEB-2044
5,68%97,58%5,500%2044-02-22500 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BRMDBristol-Myers Squibb Company 3.25% 01-AUG-2042
5,68%74,61%3,250%2042-08-01500 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DV7Bristol-Myers Squibb Company 3.55% 15-MAR-2042
5,65%78,16%3,550%2042-03-151,25 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043
5,64%95,69%5,250%2043-08-15218,37 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040
5,49%101,99%5,700%2040-10-15151,01 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DR6Bristol-Myers Squibb Company 2.35% 13-NOV-2040
5,49%69,11%2,350%2040-11-13750 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039
5,41%88,13%4,125%2039-06-152 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038
5,41%106,16%6,125%2038-05-01219,25 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY.GLBristol-Myers Squibb Company 5.875% 15-NOV-2036
5,26%104,79%5,875%2036-11-15279,22 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DZ8Bristol-Myers Squibb Company 5.9% 15-NOV-2033
4,99%105,33%5,900%2033-11-15750 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EH7Bristol-Myers Squibb Company 5.2% 22-FEB-2034
4,97%101,11%5,200%2034-02-222,5 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
AA4EKWXBMS Ireland Capital Funding DAC 4.581% 10-NOV-20554,83%96,03%4,581%2055-11-101,2 B EUR1.000,00 EUR
A
BMS Ireland Capital Funding DAC
US110122DU9Bristol-Myers Squibb Company 2.95% 15-MAR-2032
4,79%90,83%2,950%2032-03-151,75 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BRMJBristol-Myers Squibb Company 3.25% 27-FEB-2027
4,78%99,07%3,250%2027-02-27512,28 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
UUS151020BB94Celgene Corporation 3.9% 20-FEB-2028
4,75%98,69%3,900%2028-02-2043,84 M USD1.000,00 USD
A
Celgene Corp.
US110122EG9Bristol-Myers Squibb Company 5.1% 22-FEB-2031
4,68%101,51%5,100%2031-02-221,25 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DY1Bristol-Myers Squibb Company 5.75% 01-FEB-2031
4,68%104,09%5,750%2031-02-011 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030
4,55%87,92%1,450%2030-11-131,25 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
AA4EKWWBMS Ireland Capital Funding DAC 4.289% 10-NOV-20454,54%96,77%4,289%2045-11-10750 M EUR1.000,00 EUR
A
BMS Ireland Capital Funding DAC
BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029
4,53%96,85%3,400%2029-07-261,41 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027
4,52%98,59%3,450%2027-11-1516,55 M USD1.000,00 USD
A
Celgene Corp.
BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027
4,46%98,70%3,450%2027-11-15517,67 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026
4,44%100,75%6,800%2026-11-15255,95 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122EF1Bristol-Myers Squibb Company 4.9% 22-FEB-2029
4,36%101,16%4,900%2029-02-22726,69 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
US110122DP0Bristol-Myers Squibb Company 1.125% 13-NOV-2027
4,19%95,95%1,125%2027-11-131 B USD1.000,00 USD
A
Bristol Myers Squibb Co.
BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028
4,18%99,56%3,900%2028-02-20497,17 M USD1.000,00 USD
A
Bristol Myers Squibb Co.
AA4EKWVBMS Ireland Capital Funding DAC 3.857% 10-NOV-20384,05%98,12%3,857%2038-11-101,15 B EUR1.000,00 EUR
A
BMS Ireland Capital Funding DAC
XS122674851Bristol-Myers Squibb Company 1.75% 15-MAY-2035
3,74%85,23%1,750%2035-05-15575 M EUR1.000,00 EUR
A
Bristol Myers Squibb Co.
AA4EKWUBMS Ireland Capital Funding DAC 3.363% 10-NOV-20333,69%97,90%3,363%2033-11-101,15 B EUR1.000,00 EUR
A
BMS Ireland Capital Funding DAC
AA4EKWTBMS Ireland Capital Funding DAC 2.973% 10-NOV-20303,35%98,48%2,973%2030-11-10750 M EUR1.000,00 EUR
A
BMS Ireland Capital Funding DAC